Drug Industry: Pharmaceutical Companies Find Ways To Cope As Patents Expire; FDA Criticized For Consulting Contracts
The Philadelphia Inquirer: "There is a simple explanation for most of the mergers and acquisitions in the pharmaceutical world these days: the so-called Patent Cliff. Simply put, many of the drug industry's biggest earners - blockbuster medications that have paid the bills for the last decade - are about to lose their patent protections." Though patent losses will benefit consumers and insurers ...
Read more on Medical News Today
Orignal From: Drug Industry: Pharmaceutical Companies Find Ways To Cope As Patents Expire; FDA Criticized For Consulting Contracts
Post a Comment